The commercial availability of this new offering reflects the decade-long partnership between the two companies and their shared ... slim X2 insulin pump with Control-IQ was cleared for use with Eli ...
COPENHAGEN (Reuters) -Danish biotechnology company Zealand Pharma said on Tuesday it had enrolled the first patient in its so-called Phase 2b ZUPREME-1 trial with its weight-loss drug candidate ...
Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising ...